VR Logo

Codexis Inc. (CDXS) download report


Healthcare | Biotechnology & Pharma Research

Codexis Inc. (CDXS) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services.

IPO Date: 22-Apr-2010

Pres, CEO & Director: Mr. John J. Nicols

Sr. VP & CFO: Mr. Ross Taylor Jr., M.B.A.

Listing: NASDAQ: CDXS

Country: United States

Headquarters: Redwood City, CA

Website: https://www.codexis.com

Key Facts

Market cap: $726.18 Mln

Revenue (TTM): $122.06 Mln

Earnings (TTM): $-20.57 Mln

Cash: $94.26 Mln

Total Debt: $47.28 Mln

Insider's Holding: 2.52%

Liquidity: Low

52 Week range: $8.11 - 42.01

Shares outstanding: 65,304,100

10 Years Aggregate:

  • CFO: $-103.85 Mln
  • EBITDA: $-141.70 Mln
  • Net Profit: $-198.47 Mln

Stock Performance

Time Period Codexis (CDXS) S&P BSE Sensex S&P Small-Cap 600
YTD-66.93-8.99-19.23
1 month-6.43-3.40-9.35
3 months-51.18-8.50-16.59
1 Year-56.750.89-17.36
3 Years-17.5210.415.90
5 Years14.5211.435.77
10 Years10.7911.779.78
As on 30-Jun-2022
Year Codexis (CDXS) S&P Small-Cap 600 S&P BSE Sensex
202143.2425.2721.99
202036.529.5715.75
2019-4.2520.8614.38
201899.25-9.705.87
201781.5211.7327.91
20168.7524.741.95
201567.86-3.36-5.03